Deutsche Bank Remains a Sell on Roche Holding AG (RHHVF)
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Sell rating on Roche Holding AG (RHHVF – Research ...
Deutsche Bank Sticks to Their Sell Rating for Sanofi (SNYNF)
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Sell rating on Sanofi (SNYNF – Research Report), with a ...
Deutsche Bank Reaffirms Their Buy Rating on Novo Nordisk (0QIU)
In a report released on October 10, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on Novo Nordisk (0QIU – Research ...
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sanofi (OtherSNYNF) and Viking Therapeutics (VKTX)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sanofi (SNYNF – Research Report) and Viking ...
BioNTech SE (BNTX) Gets a Buy from Deutsche Bank
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on BioNTech SE (BNTX – Research Report), with ...
Novo Nordisk Is Still a Buy, Analysts Say. Slowing Growth for Ozempic and Wegovy Isn’t a Problem.
“Present weakness represents a good entry opportunity,” Deutsche Bank analyst Emmanuel Papadakis wrote in a note, reiterating ...
Deutsche Bank Sticks to Their Sell Rating for Roche Holding AG (RHHVF)
Deutsche Bank analyst Emmanuel Papadakis maintained a Sell rating on Roche Holding AG (RHHVF – Research Report) today and set a price ...
GSK’s problem is it has more than one source of pain
Zantac settlement should ease investors’ nervousness but long-standing concerns about drugmaker’s pipeline remain ...
Citi Keeps Their Buy Rating on GlaxoSmithKline (GSK)
Citi analyst Peter Verdult maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £19.00. The ...
Business Insider28d
J.P. Morgan Sticks to Their Buy Rating for Novo Nordisk (0QIU)
In addition to J.P. Morgan, Novo Nordisk also received a Buy from Deutsche Bank ‘s Emmanuel Papadakis in a report issued yesterday. However, today, Jefferies maintained a Sell rating on Novo ...